SHARP-VT is designed to support non-invasive cardiac radioablation. It integrates data from CT, MRI, PET, and electroanatomic maps into a unified 3D treatment planning tool, allowing accurate target delineation and direct export to radiotherapy systems for treatment. It is the first software offering tools specifically for cardiac radiotherapy, streamlining workflows and enabling broader clinical adoption
Contact us to learn more!
Connor is an innovative biomedical engineer and creator of SHARP-VT through his PhD at Carleton University. He has prior experience in transcatheter mitral valve design and development, where he supported feasibility and CE Mark trials for a class III medical device.
Dr. Calum Redpath is a global leader in non-invasive cardiac radioablation. He performed the first radioablation in Canada in 2020, and now leads the CARA-VT trial, a first-of-its-kind randomized trial comparing cardiac radioablation with catheter ablation, the current standard of care.
Dr. Robert deKemp is a renowned physicist in nuclear imaging. He has prior experience successfully commercializing Rubidium PET technology through his research at the University of Ottawa Heart Institute.
“You just get so much more precision. It’s easy to identify exactly where you’re targeting” – Electrophysiologist
“I didn't believe the ECG imaging until I saw it all put together [in SHARP-VT]” – Another electrophysiologist
“I don't think we could have done this [treatment plan] without [SHARP-VT]” – Imaging cardiologist
